- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03258918
A Low-Carbohydrate Diabetes Prevention Program
A Mixed Methods Pilot Study of a Low-Carbohydrate Diabetes Prevention Program Among Individuals With Prediabetes
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
An estimated 86 million US adults are have prediabetes, and, without intervention, many will develop T2DM over time. Fortunately, T2DM can be prevented or delayed through modest lifestyle changes. The landmark Diabetes Prevention Program (DPP) Trial demonstrated a 58 percent reduction in the 3-year incidence of T2DM among individuals with prediabetes who achieved 7 percent body weight loss and engaged in routine physical activity. Accordingly, the DPP lifestyle intervention has been translated to communities across the United States, and, on average, participant weight change is 4 percent at 12 months. Thus, while group-based DPPs and can effectively promote weight loss among some participants, many DPP participants do not achieve the program goal of 5 to 7 percent body weight loss.
Novel strategies to help participants achieve DPP weight-loss goals are important for two key reasons. First, weight loss is the primary driver of T2DM risk reduction, and the potential population health impact of the intervention is diminished when participants do not lose weight. Second, a growing number of health plans including Medicare offer coverage for the DPP and proposed reimbursement is largely tied to weight loss of at least 5 percent at 6 months and 12 months. The DPP costs approximately $400-$500 per participant per year. Unfortunately, organizations that offer the DPP may be reimbursed for much less than this if participants do not meet weight loss goals, which could significantly compromise the program's long-term financial sustainability.
One promising approach to help DPP participants lose more weight may be through a low-carbohydrate (LC) dietary intervention. Consistent with United States Dietary Guidelines (USDG), the original DPP Trial and translational group-based curricula recommend a low-fat (LF), calorie-restricted diet. However, there is growing controversy regarding the scientific merit of the Dietary Guidelines as well as growing recognition that LC diets may be more effective than LF diets for short-term weight loss and long-term weight maintenance. Notably, weight loss occurs without calorie restriction and LC diets improve blood glucose levels among individuals with T2DM and insulin resistance. Thus, a LC dietary intervention for prediabetes may augment individual weight loss and T2DM risk reduction while also maximizing third-party reimbursement.
The aim of this mixed methods pilot study is to test whether a LC-DPP may lead to greater weight loss than the original DPP. In addition to objective measures of this program's preliminary efficacy (e.g. weight, HbA1c) the study team will also obtain qualitative participant feedback on the intervention. Taken together, these data will be used to improve the curriculum and inform a larger-scale intervention.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Michigan
-
Ann Arbor, Michigan, Estados Unidos, 48109
- Michigan Medicine
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion criteria:
- Overweight, defined as BMI≥25 kg/m2 [31]
- HbA1c between 5.7-6.4% drawn within 6 months of the study start date
- Willingness to participate in group-based classes
- Able to engage in at least light physical activities such as walking.
Exclusion criteria:
- History of type 1 diabetes or type 2 diabetes
- Current participation in another lifestyle or behavior change program or research study
- Vegetarian or vegan lifestyle
- History of bariatric surgery
- Inability to read, write, or speak English
- Inability to provide informed consent
- Women who are pregnant or intend to become pregnant during the intervention period.
- Insured by Premier Care or Grad Care; these individuals have the opportunity to participate in a standard DPP, which is offered as a covered benefit through their health plan.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: Low-Carbohydrate Diabetes Prevention Program
At least 20 individuals with prediabetes will participate in a year-long , group-based program.
|
LC-DPP participants will be instructed to follow ad-libitum very low-carbohydrate, ketogenic diet, which restricts carbohydrate intake (not including fiber) to 20-35 grams per day with the goal of achieving nutritional ketosis.
Participants will be encouraged to eat a normal amount of protein (roughly 80-120 grams per day) and to derive the remaining calories from fat.
Allowable foods include: meats, fish, poultry, eggs, cheese, seeds, nuts, leafy greens, non-starchy vegetables, and some fruits.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Change in body weight per participant over the study period
Prazo: Baseline, 12 months
|
Measured as percent body weight loss per participant
|
Baseline, 12 months
|
Percentage of participants who achieve weight loss goal
Prazo: Baseline,12 months
|
Measured as percentange of participants who achieve 5% total body weight loss
|
Baseline,12 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Change in self-reported weekly physical activity minutes
Prazo: Baseline, 12 months
|
Participants will maintain a log of weekly physical activity minutes
|
Baseline, 12 months
|
Change in physical activity measured using the International Physical Activity Questionnaire
Prazo: Baseline, 12 months
|
Participants will complete this validated survey
|
Baseline, 12 months
|
Change in food cravings measured using the Control of Eating Questionnaire
Prazo: Baseline, 12 months
|
Participants will complete this validated survey
|
Baseline, 12 months
|
Change in stress eating measured using the Palatable Eating Motives Scale
Prazo: Baseline, 12 months
|
Participants will complete this validated survey
|
Baseline, 12 months
|
Change in self-reported health measured using the Global Health PROMIS Questionnaire
Prazo: Baseline, 12 months
|
Participants will complete this validated survey
|
Baseline, 12 months
|
Change in autonomous motivation measured using the Treatment Self-Regulation Questionnaire
Prazo: Baseline, 12 months
|
Participants will complete this validated survey
|
Baseline, 12 months
|
Change in hemoglobin A1c
Prazo: Baseline, 12 months
|
Measured using a laboratory blood draw
|
Baseline, 12 months
|
Session attendance
Prazo: Baseline, 12 months
|
Measured as the number of sessions attended per participant
|
Baseline, 12 months
|
Study attrition
Prazo: Baseline, 12 months
|
Number of participants lost to follow-up
|
Baseline, 12 months
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Change in diet as assessed by qualitative review of foods logs
Prazo: Baseline, 12 months
|
Participants will maintain weekly food logs
|
Baseline, 12 months
|
Change in diet as assessed by response to survey questions
Prazo: Baseline, 12 months
|
Participants will respond to exploratory survey questions about diet created by the study team.
|
Baseline, 12 months
|
Change in physical symptoms
Prazo: Baseline, 12 months
|
Participants will respond to exploratory survey questions about physical symptoms created by the study team.
|
Baseline, 12 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- F046400
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .